logo image

HIV Molecular Immunology Database

Search the Epitope Variant and Escape Mutation Database

Results for CTL/CD8+ T-Cell Epitope Variants

Filter results by Mutation Type:

DVGDAYFSVPLDKDFRKY Pol(265-282) human epitope
    AYFSVPLDKDFRKYT Pol(269-283) C*07:02 human epitope
     YFSVPLDEGFRKYTA Pol(270-284) human epitope
     YFSVPLDEGFRKYTA Pol(270-284) human epitope
     YFSVPLDEGFRKYTA Pol(270-284) human epitope
      FSVPLDEDFRKYTAFTIPSI Pol(271-290) human epitope
       SVPLDKDFRKYTAFTI Pol(272-287) human epitope
       SVPLDeDFRKYTAFTI Pol(272-287) non-susceptible form
        VPLDEDFRKY Pol(273-282) A*03 human epitope
        VPLDEDFRKY Pol(273-282) B*15:02 human epitope
        VPLDEDFRKY Pol(273-282) B*35 human epitope
        VPLDEDFRKY Pol(273-282) B*35 human epitope
        VPLDEDFRKY Pol(273-282) B*35 human epitope
        VPLDKDFRKY Pol(273-282) B*35 human epitope
        VPLDEDFRKY Pol(273-282) B*35 human epitope
        VPLDEDFRKY Pol(273-282) B*35 epitope
        VPLDEDFRKY Pol(273-282) B*35 human epitope
        iPLDEDFRKY Pol(273-282) HLA association; non-susceptible form; susceptible form
        VPLDkDFRKY Pol(273-282) observed variant
        VPLDkxFRKY Pol(273-282) observed variant
        VPLDEnFRKY Pol(273-282) observed variant
        VPLDxxFRKY Pol(273-282) observed variant
        VPLDEDFRKY Pol(273-282) B35 human epitope
        VPLDKDFRKY Pol(273-282) B35 human epitope
        VPLDEDFRKY Pol(273-282) B35 human epitope
        VPLhEDFRKY Pol(273-282) non-susceptible form
        VPLDkDFRKY Pol(273-282) non-susceptible form
        VPhDEDFRKY Pol(273-282) non-susceptible form
        VPLDKDFRKY Pol(273-282) B35 human epitope
        VPLDKeFRKY Pol(273-282) susceptible form
        VPLDEDFRKY Pol(273-282) B35 human epitope
        VPLDEDFRKY Pol(273-282) B*35:01, B35 human epitope
        VPLDEGFRKY Pol(273-282) B*35:01 human epitope
        VPLDKDFRKY Pol(273-282) B*35:01 human epitope
        VPLDkDFRKY Pol(273-282) susceptible form
        VPLDEDFRKY Pol(273-282) B*35:01 human epitope
        VPLDKDFRKY Pol(273-282) B*35:01 human epitope
        VPLDEDFRKY Pol(273-282) B*35:01 human epitope
        VPLDEDFRKY Pol(273-282) B*35:01 human epitope
        VPLDEDFRKY Pol(273-282) B*35:01 human epitope
        VPLDKDFRKY Pol(273-282) B*35:01 human epitope
        VPLDKDFRKY Pol(273-282) B*35:01 human epitope
        VPLDEGFRKY Pol(273-282) B*35:01 human epitope
        VPLDKDFRKY Pol(273-282) B*35:01 human epitope
        VPLDEDFRKY Pol(273-282) B*35:01 human epitope
        VPLDKDFRKY Pol(273-282) B*35:01 human epitope
        VPLDEDFRKY Pol(273-282) B*35:02, B*35:03, B*53:01 human epitope
        VPLDEDFRKY Pol(273-282) B*42:01 human epitope
        VPLDEDFRKY Pol(273-282) C*14 human epitope
        VPLDKDFRKY Pol(273-282) human epitope
        VPLDeDFRKY Pol(273-282) observed variant
        VPLDEDFRKY Pol(273-282) human epitope
        VPLDEDFRKY Pol(273-282) human epitope
        VPLDKDFRKYTAFTI Pol(273-287) C*07:02 human epitope
        VPLDKEFRKYTAFTIPSI Pol(273-290) human epitope
        VPLDKDFRKYTAFTIPSI Pol(273-290) human epitope
         PLDEGFRKY Pol(274-282) B*35:01 human epitope
         PLDESFRKY Pol(274-282) human epitope
         PLDEDFRKY Pol(274-282) human epitope
         PLDEGFRKYTAFTIP Pol(274-288) human epitope
         PLDEGFRKYTAFTIP Pol(274-288) human epitope
         PLDEGFRKYTAFTIP Pol(274-288) human epitope
             GFRKYTAFTIPSINN Pol(278-292) human epitope
             GFRKYTAFTIPSINN Pol(278-292) human epitope
             GFRKYTAFTIPSINN Pol(278-292) human epitope
                KYTAFTIPSI Pol(281-290) A*02:01 human epitope
                KYTAFTIPSI Pol(281-290) A2 human epitope
                KYTAFTIPSI Pol(281-290) human epitope
                KYTAFTIPSINNETP Pol(281-295) human epitope
                KYTAFTIPSINNETPGIR Pol(281-298) human epitope
                 YTAFTIPSI Pol(282-290) A*02 human epitope
                 YTAFTIPSI Pol(282-290) A*02 human epitope
                 YTAFTIPSv Pol(282-290) observed variant
                 YTAFTIPSV Pol(282-290) A*02 human epitope
                 YTAFTIPSI Pol(282-290) A*02:01 human epitope
                 YTAFTIPSI Pol(282-290) A*02:05 human epitope
                 YTAFTIPSI Pol(282-290) A*02:06 human epitope
                 YTAFTIPSI Pol(282-290) A*02:06 human epitope
                 YTAFTIPSI Pol(282-290) A*02:06 human epitope
                 YTAFTIPSI Pol(282-290) A*11 human epitope
                 YTAFTIPSV Pol(282-290) A2 human epitope
                 YTAFTIPSI Pol(282-290) A2 human epitope
                 YTAFTIPSI Pol(282-290) A2 human epitope
                 YTAFTIPSI Pol(282-290) A2 human epitope
                 YTAFTIPSI Pol(282-290) A2 human epitope
                 YTAFTIPSV Pol(282-290) A2 human epitope
                 YTAFTIPSI Pol(282-290) A2 human epitope
                 YTAFTIPSI Pol(282-290) A2 human epitope
                 YTAFTIPSV Pol(282-290) A2 human epitope
                 YTAFTIPSi Pol(282-290) diminished response
                 YTAFTIPSI Pol(282-290) A2 supertype human epitope
                 YTAFTIPSI Pol(282-290) A*66 human epitope
                 YTAFTIPSI Pol(282-290) B*35:02, B*35:03, B*53:01 human epitope
                 YTAFTIPSI Pol(282-290) B*51 human epitope
                 YTAFTIPSI Pol(282-290) C*01 human epitope
                 YTAFTIPSI Pol(282-290) human epitope
                 YTAFTIPSI Pol(282-290) human epitope
                 YTAFTIPSINNETPG Pol(282-296) human epitope
                 YTAFTIPSINNETPG Pol(282-296) human epitope
                 YTAFTIPSINNETPG Pol(282-296) human epitope
                  TAFTIPSI Pol(283-290) A*02:01 human epitope
                  TAFTIPSI Pol(283-290) A*02:01, B*51:01 human epitope
                  TAFTIPSI Pol(283-290) A*02:17, B*51:01 human epitope
                  TAFTIPSI Pol(283-290) A*23 human epitope
                  TAFTIPSI Pol(283-290) A*24 human epitope
                  TAFTIPSI Pol(283-290) A*66 human epitope
                  TAFTIPSI Pol(283-290) B*35:02, B*35:03, B*53:01 human epitope
                  TAFTIPSI Pol(283-290) B*40 human epitope
                  TAFTIPSI Pol(283-290) B*51 human epitope
                  TAFTIPSt Pol(283-290) diminished HLA binding or increased off-rate
                  TAFTIPSr Pol(283-290) diminished HLA binding or increased off-rate
                  TAFTIPSI Pol(283-290) B*51 human epitope
                  TAFTIPSI Pol(283-290) B*51 human epitope
                  TAFTIPSI Pol(283-290) B*51 human epitope
                  TAFTIPSl Pol(283-290) escape documented in this paper
                  TAFTIPSv Pol(283-290) escape documented in this paper
                  TAFTIPSt Pol(283-290) escape documented in this paper
                  TAFTIPSr Pol(283-290) escape documented in this paper
                  TAFTIPSV Pol(283-290) B*51 human epitope
                  TAFTIPSi Pol(283-290)
                  TAFTIPSl Pol(283-290) diminished HLA binding or increased off-rate; susceptible form
                  TAFTIPSt Pol(283-290) diminished HLA binding or increased off-rate
                  TAFTIPSr Pol(283-290) non-susceptible form
                  TAFTIPSI Pol(283-290) B*51 human epitope
                  TAFTIPSI Pol(283-290) B*51 human epitope
                  TAFTIPSt Pol(283-290) escape documented in this paper
                  TAFTIPSI Pol(283-290) B*51 human epitope
                  TAFTIPSt Pol(283-290) calculated escape
                  TAFTIPSm Pol(283-290) observed variant
                  TAFTIPSr Pol(283-290) observed variant
                  TAFTvPSt Pol(283-290) observed variant
                  TAFTIPSI Pol(283-290) B*51 human epitope
                  TAFTIPSI Pol(283-290) B*51, B*52 human epitope
                  TAFTIPSI Pol(283-290) B51 human epitope
                  TAFTIPSI Pol(283-290) B51 human epitope
                  TAFTIPSI Pol(283-290) B51 human epitope
                  TAFTIPSI Pol(283-290) B51 human epitope
                  TAFTIPSt Pol(283-290) susceptible form
                  TAFTIPSv Pol(283-290) susceptible form
                  TvFTIPSI Pol(283-290) non-susceptible form
                  TAFTIPSt Pol(283-290) diminished response
                  TAFTIPSv Pol(283-290) diminished response
                  TvFTIPSt Pol(283-290) diminished response
                  TAFTIPSI Pol(283-290) B51 human epitope
                  TAFTIPSI Pol(283-290) B51 human epitope
                  TAFTIPSI Pol(283-290) B51 human epitope
                  TAFTIPSI Pol(283-290) B51 human epitope
                  TAFTIPSt Pol(283-290) escape documented in this paper
                  TAFTIPSI Pol(283-290) B51 human epitope
                  TAFTIPSI Pol(283-290) B51 human epitope
                  TAFTIPSI Pol(283-290) B51 human epitope
                  TAFTIPSI Pol(283-290) B51 human epitope
                  TAFTIPSt Pol(283-290) diminished response; susceptible form
                  TAFTIPSm Pol(283-290) diminished response; susceptible form
                  TAFTIPSI Pol(283-290) B51 human epitope
                  TAFTIPSI Pol(283-290) B51 human epitope
                  TAFTIPSI Pol(283-290) B*51:01 human epitope
                  TAFTIPSI Pol(283-290) B*51:01 human epitope
                  TAFTIPSI Pol(283-290) B*51:01 human epitope
                  TAFTIPSI Pol(283-290) B*51:01 human epitope
                  TAFTIPSI Pol(283-290) B*51:01 human epitope
                  TAFTIPSv Pol(283-290) escape documented in this paper
                  TAFTIPSI Pol(283-290) B*51:01 human epitope
                  TAFTIPSt Pol(283-290) diminished response
                  TAFTIPSr Pol(283-290) diminished response
                  TAFTIPSv Pol(283-290) diminished response
                  TAFTIPSI Pol(283-290) B*51:01 human epitope
                  TAFTIPSt Pol(283-290) diminished HLA binding or increased off-rate; escape documented in this paper
                  TAFTIPSr Pol(283-290) diminished HLA binding or increased off-rate; escape documented in this paper
                  TAFTIPSI Pol(283-290) B*51:01 human epitope
                  TAFTIPSI Pol(283-290) B*51:01 human epitope
                  TAFTIPSt Pol(283-290) diminished response; escape documented in this paper; non-susceptible form
                  TAFTIPSv Pol(283-290) diminished response; escape documented in this paper; non-susceptible form
                  TAFTIPSI Pol(283-290) B*51:01 human epitope
                  TAFTIPSI Pol(283-290) B*51:01 human epitope
                  TAFTIPSx Pol(283-290) escape documented in this paper
                  TAFTIPSt Pol(283-290) calculated diminished HLA binding; observed variant
                  TAFTIPSI Pol(283-290) B*51:01 human epitope
                  TAFTIPSt Pol(283-290) diminished response
                  TAFTIPSr Pol(283-290) diminished response
                  TAFTIPSv Pol(283-290) diminished response
                  TAFTIPSI Pol(283-290) B*51:01 human epitope
                  TAFTIPSI Pol(283-290) B*51:01 human epitope
                  TAFTIPSv Pol(283-290) diminished response
                  TAFTIPSr Pol(283-290) diminished response
                  TAFTIPSt Pol(283-290) diminished response
                  TAFTIPSI Pol(283-290) B*51:01 human epitope
                  TAFTIPSI Pol(283-290) B*51:01 human epitope
                  TvFTIPSI Pol(283-290) observed variant
                  TAFTIPSt Pol(283-290) observed variant
                  TAFTIPSv Pol(283-290) observed variant
                  TAFTIPSI Pol(283-290) B*51:01 human epitope
                  TAFTIPSt Pol(283-290) escape documented in this paper
                  TAFTIPSr Pol(283-290) escape documented in this paper
                  TAFTIPSl Pol(283-290) escape documented in this paper
                  TAFTIPSI Pol(283-290) B*51:01 human epitope
                  TAFTIPSI Pol(283-290) B*51:01, B*52:01 human epitope
                  TAFTIPSt Pol(283-290) observed variant
                  TAFTIPSl Pol(283-290) observed variant
                  TAFTIPSv Pol(283-290) observed variant
                  TAFTIPSr Pol(283-290) observed variant
                  TAFTIPSm Pol(283-290) observed variant
                  TAFTIPSI Pol(283-290) B*52:01 human epitope
                  TAFTIPSI Pol(283-290) C*12 human epitope
                  TAFTIPSI Pol(283-290) human epitope
                  TAFTIPSI Pol(283-290) human epitope
                  TAFTIPSI Pol(283-290) human epitope
                  TAFTIPSI Pol(283-290) human epitope
                  TAFTIPSI Pol(283-290) human epitope
                  TAFTIPSI Pol(283-290) human epitope
                  TAFTIPSI Pol(283-290) human epitope
                  TAFTIPSI Pol(283-290) human epitope
                  TAFTIPSv Pol(283-290) escape documented in this paper; replicative capacity reduced; susceptible form
                  TAFTvPSv Pol(283-290) escape documented in this paper; susceptible form
                  TAFTIPSIN Pol(283-291) human epitope
                    FTIPSINNETPGIRY Pol(285-299) A25 human epitope
                     TIPSINNETPGIRYQ Pol(286-300) human epitope
                     TIPSINNETPGIRYQ Pol(286-300) human epitope
                      IPSTNNETPG Pol(287-296) B7 human epitope
                       PSINNETPG Pol(288-296) human epitope
                        STNNETPGVRY Pol(289-299) B*18 human epitope
                        SINNETPGIRYQYNVLPQ Pol(289-306) human epitope
                         INNETPGIRYQYNVL Pol(290-304) human epitope
Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy's National Nuclear Security Administration
Copyright Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services LANL logo National Institutes of Health logo